Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05644327 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Exercise to Improve Sleep in Parkinson's Disease

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: Dec 1, 2026 to Dec 30, 2027 Primary endpoints revised (5) · Completion date: Sep 1, 2027 to Dec 30, 2027 · Eligibility criteria expanded, about 9 wordsv3 Show 3 more changesShow less
    • Primary endpoints revised (5)
    • Completion date: Sep 1, 2027 to Dec 30, 2027
    • Eligibility criteria expanded, about 9 words

    See this version in full on ClinicalTrials.gov ↗

  2. Re-verified, no change to tracked fieldsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will investigate the impact of three common exercise modalities, cardiovascular, resistance, and multimodal (i.e., a combination of the previous two) training, on sleep quality and architecture in persons with Parkinson's disease (PD). Furthermore, the project will investigate whether the potential positive exercise-induced changes in sleep are associated with improvements in different quality of life (QoL)-related aspects. Participants will perform either cardiovascular training (CT), resistance training (RT), multimodal training (MT), or will be allocated to a control condition (i.e., waiting list - CON) for 12 weeks. Training will be performed three times/week. The assessments will be conducted at baseline, post-intervention, and follow-up (i.e. 8 weeks after the intervention) by assessors blinded to the participants' group allocation.
Trial Details
NCT Number NCT05644327
Lead Sponsor McGill University
Collaborators: Jewish Rehabilitation Hospital, The Memory Lab, The Human Brain Control of Locomotion Lab (HBCL), The Cummings Centre, Canadian Institutes of Health Research (CIHR)
Conditions Parkinson Disease
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov